Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Chugai Pharmaceutical Co., Ltd.

CHGCY•PNK
Healthcare
Drug Manufacturers - General
$33.03
$0.92(2.87%)
U.S. Market opens in 8h 20m

Chugai Pharmaceutical Co., Ltd. (CHGCY) Stock Overview

Explore Chugai Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap109.4B
P/E Ratio36.64
EPS (TTM)$0.86
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$26.53
3 Months$27.33
1 Year Target$31.98

CHGCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chugai Pharmaceutical Co., Ltd. (CHGCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 76.52, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $31.98.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.64 and a market capitalization of 109.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.27%
5-Day Change
8.54%
1-Month Change
19.58%
3-Month Change
23.50%
6-Month Change
54.81%
Year-to-Date (YTD) Change
25.61%
1-Year Change
30.50%
3-Year Change
152.94%
5-Year Change
33.33%
All-Time (Max) Change
987.21%

Contact Information

https://www.chugai-pharm.co.jp
81 3 3281 6611
Nihonbashi Mitsui Tower, Tokyo, NaN, 103-8324

Company Facts

50,260 Employees
IPO DateAug 3, 2012
CountryJP
Actively Trading

Frequently Asked Questions